Literature DB >> 24316976

LRIG1 inhibits STAT3-dependent inflammation to maintain corneal homeostasis.

Takahiro Nakamura, Junji Hamuro, Mikiro Takaishi, Szandor Simmons, Kazuichi Maruyama, Andrea Zaffalon, Adam J Bentley, Satoshi Kawasaki, Maho Nagata-Takaoka, Nigel J Fullwood, Satoshi Itami, Shigetoshi Sano, Masaru Ishii, Yann Barrandon, Shigeru Kinoshita.   

Abstract

Corneal integrity and transparency are indispensable for good vision. Cornea homeostasis is entirely dependent upon corneal stem cells, which are required for complex wound-healing processes that restore corneal integrity following epithelial damage. Here, we found that leucine-rich repeats and immunoglobulin-like domains 1 (LRIG1) is highly expressed in the human holoclone-type corneal epithelial stem cell population and sporadically expressed in the basal cells of ocular-surface epithelium. In murine models, LRIG1 regulated corneal epithelial cell fate during wound repair. Deletion of Lrig1 resulted in impaired stem cell recruitment following injury and promoted a cell-fate switch from transparent epithelium to keratinized skin-like epidermis, which led to corneal blindness. In addition, we determined that LRIG1 is a negative regulator of the STAT3-dependent inflammatory pathway. Inhibition of STAT3 in corneas of Lrig1-/- mice rescued pathological phenotypes and prevented corneal opacity. Additionally, transgenic mice that expressed a constitutively active form of STAT3 in the corneal epithelium had abnormal features, including corneal plaques and neovascularization similar to that found in Lrig1-/- mice. Bone marrow chimera experiments indicated that LRIG1 also coordinates the function of bone marrow-derived inflammatory cells. Together, our data indicate that LRIG1 orchestrates corneal-tissue transparency and cell fate during repair, and identify LRIG1 as a key regulator of tissue homeostasis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24316976      PMCID: PMC3871248          DOI: 10.1172/JCI71488

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  49 in total

1.  Identification of human oral keratinocyte stem/progenitor cells by neurotrophin receptor p75 and the role of neurotrophin/p75 signaling.

Authors:  Takahiro Nakamura; Ken-ichi Endo; Shigeru Kinoshita
Journal:  Stem Cells       Date:  2006-11-16       Impact factor: 6.277

2.  Neural conversion of ES cells by an inductive activity on human amniotic membrane matrix.

Authors:  Morio Ueno; Michiru Matsumura; Kiichi Watanabe; Takahiro Nakamura; Fumitaka Osakada; Masayo Takahashi; Hiroshi Kawasaki; Shigeru Kinoshita; Yoshiki Sasai
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-09       Impact factor: 11.205

Review 3.  Regeneration of squamous epithelia from stem cells of cultured grafts.

Authors:  Michele De Luca; Graziella Pellegrini; Howard Green
Journal:  Regen Med       Date:  2006-01       Impact factor: 3.806

Review 4.  Epithelial stem cells: turning over new leaves.

Authors:  Cédric Blanpain; Valerie Horsley; Elaine Fuchs
Journal:  Cell       Date:  2007-02-09       Impact factor: 41.582

5.  LRIG1 is a novel negative regulator of the Met receptor and opposes Met and Her2 synergy.

Authors:  David L Shattuck; Jamie K Miller; Melanie Laederich; Melanie Funes; Heidi Petersen; Kermit L Carraway; Colleen Sweeney
Journal:  Mol Cell Biol       Date:  2006-12-18       Impact factor: 4.272

6.  Single-cell expression profiling of human epidermal stem and transit-amplifying cells: Lrig1 is a regulator of stem cell quiescence.

Authors:  Kim B Jensen; Fiona M Watt
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-28       Impact factor: 11.205

7.  Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model.

Authors:  Shigetoshi Sano; Keith Syson Chan; Steve Carbajal; John Clifford; Mary Peavey; Kaoru Kiguchi; Satoshi Itami; Brian J Nickoloff; John DiGiovanni
Journal:  Nat Med       Date:  2004-12-12       Impact factor: 53.440

8.  A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells.

Authors:  Hui Song; Renxiao Wang; Shaomeng Wang; Jiayuh Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-21       Impact factor: 11.205

9.  SOCS-3 negatively regulates innate and adaptive immune mechanisms in acute IL-1-dependent inflammatory arthritis.

Authors:  Peter K K Wong; Paul J Egan; Ben A Croker; Kristy O'Donnell; Natalie A Sims; Sarah Drake; Hiu Kiu; Edward J McManus; Warren S Alexander; Andrew W Roberts; Ian P Wicks
Journal:  J Clin Invest       Date:  2006-05-18       Impact factor: 14.808

Review 10.  Altered macrophage differentiation and immune dysfunction in tumor development.

Authors:  Antonio Sica; Vincenzo Bronte
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

View more
  23 in total

1.  Ocular surface reconstruction with a tissue-engineered nasal mucosal epithelial cell sheet for the treatment of severe ocular surface diseases.

Authors:  Masakazu Kobayashi; Takahiro Nakamura; Makoto Yasuda; Yuiko Hata; Shoki Okura; Miyu Iwamoto; Maho Nagata; Nigel J Fullwood; Noriko Koizumi; Yasuo Hisa; Shigeru Kinoshita
Journal:  Stem Cells Transl Med       Date:  2014-11-19       Impact factor: 6.940

2.  Lrig1 is a cell-intrinsic modulator of hippocampal dendrite complexity and BDNF signaling.

Authors:  Fernando Cruz Alsina; Francisco Javier Hita; Paula Aldana Fontanet; Dolores Irala; Håkan Hedman; Fernanda Ledda; Gustavo Paratcha
Journal:  EMBO Rep       Date:  2016-03-02       Impact factor: 8.807

3.  LRIG1 Regulates Ontogeny of Smooth Muscle-Derived Subsets of Interstitial Cells of Cajal in Mice.

Authors:  Jumpei Kondo; Anne E Powell; Yang Wang; Melissa A Musser; E Michelle Southard-Smith; Jeffrey L Franklin; Robert J Coffey
Journal:  Gastroenterology       Date:  2015-04-25       Impact factor: 22.682

Review 4.  The LRIG family: enigmatic regulators of growth factor receptor signaling.

Authors:  Catalina Simion; Maria Elvira Cedano-Prieto; Colleen Sweeney
Journal:  Endocr Relat Cancer       Date:  2014-09-02       Impact factor: 5.678

Review 5.  LRIG1, a regulator of stem cell quiescence and a pleiotropic feedback tumor suppressor.

Authors:  Yibing Ji; Rahul Kumar; Abhiram Gokhale; Hseu-Ping Chao; Kiera Rycaj; Xin Chen; Qiuhui Li; Dean G Tang
Journal:  Semin Cancer Biol       Date:  2021-01-18       Impact factor: 17.012

6.  Two-photon live imaging of single corneal stem cells reveals compartmentalized organization of the limbal niche.

Authors:  Olivia Farrelly; Yoko Suzuki-Horiuchi; Megan Brewster; Paola Kuri; Sixia Huang; Gabriella Rice; Hyunjin Bae; Jianming Xu; Tzvete Dentchev; Vivian Lee; Panteleimon Rompolas
Journal:  Cell Stem Cell       Date:  2021-05-12       Impact factor: 25.269

7.  JBP485 promotes tear and mucin secretion in ocular surface epithelia.

Authors:  Takahiro Nakamura; Yuiko Hata; Maho Nagata; Norihiko Yokoi; Shumpei Yamaguchi; Taiichi Kaku; Shigeru Kinoshita
Journal:  Sci Rep       Date:  2015-05-21       Impact factor: 4.379

Review 8.  LRIG and cancer prognosis.

Authors:  David Lindquist; Samuel Kvarnbrink; Roger Henriksson; Håkan Hedman
Journal:  Acta Oncol       Date:  2014-09-02       Impact factor: 4.089

9.  LRIG1 as a potential novel marker for neoplastic transformation in ocular surface squamous neoplasia.

Authors:  Maho Nagata; Takahiro Nakamura; Chie Sotozono; Tsutomu Inatomi; Norihiko Yokoi; Shigeru Kinoshita
Journal:  PLoS One       Date:  2014-04-07       Impact factor: 3.240

10.  LRIG1 opposes epithelial-to-mesenchymal transition and inhibits invasion of basal-like breast cancer cells.

Authors:  N Yokdang; J Hatakeyama; J H Wald; C Simion; J D Tellez; D Z Chang; M M Swamynathan; M Chen; W J Murphy; K L Carraway Iii; C Sweeney
Journal:  Oncogene       Date:  2015-09-21       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.